Morris Karmazyn, Professor

Dr. Karmazyn was a well-known professor as well as a scientist. He held faculty positions as a Professor of Pharmacology at Dalhousie University in Halifax, Nova Scotia, Canada and the University of Western Ontario, London, Canada. He was not only an excellent teaching professor but also a renowned expert in the field of cardiovascular research. During near His research interests mainly focused on cardiac hypertrophy; heart failure; sodium hydrogen exchange (NHE1); adipokines; Probiotic; Leptin and traditional Chinese medicine. 

Dr. Karmazyn’s heart research led to the publication of more than 234 peer-reviewed papers with an H index of 64 (Google Scholar 2021). In addition to numerous book chapters, he also edited or co-edited books dealing with cardiac pathologies and he presented more than 200 invited lectures. He served on the Editorial Boards of numerous journals and Canadian and American grant review panels of several national granting agencies.  He was also a member of NIH special competition committees and also consulted for several pharmaceutical companies. His heart research was funded throughout his independent career by the Heart and Stroke Foundation, the Canadian Institutes of Health Research in Canada as well as pharmaceutical companies.

Dr. Karmazyn was the recipient of numerous research awards–including: Tier 1 Canada Research Chair in Experimental Cardiology (2004-2018); Heart and Stroke Foundation of Ontario Career Investigator Award (1990-2003);    Merck     Frost    Award   of   the Pharmacological Society of Canada (1990); Award of Excellence from the Faculty of Medicine, University of Western Ontario (1993); Vincenzo Panagia Award from the Institute of Cardiovascular Sciences, St Boniface Hospital Research Center (2001); Fellow (elected) of the International Academy of Cardiovascular Sciences, Howard E Morgan Award for Excellence in Cardiovascular Research of the International Academy of Cardiovascular Sciences (IACS 2016).  Distinguished Service Award for Promoting Heart Health (IACS, 2026).

After his retirement in 2018, he continued to publish and consult on research. He served on the Editorial Boards of numerous journals and most recently served as Guest Editor for a focused issue of Molecules (2019). He is currently an Editor of the Special Issue "Cardiovascular Diseases Prevention and Therapy" by MDPI, an elected fellow of the IACS (International Academy of Cardiovascular well as a scientific advisor of RTx. Inc (Resuscitation Therapeutics) in Chicago.advisor of RTx. Inc (Resuscitation Therapeutics) in Chicago. It was his love of teaching and sciences to inspire young generations to pursue a career in the heart field. ”Dr. Morris Karmazyn and Dr. Margaret P. Moffat Fellowship in Cardiovascular Research” at McGill University has been set up in 2022 and continuing posthumously, majorly designated for McGill PhD students pursuing heart research (Dr. Moffat was a professor and his beloved wife who passed away in a car accident in 1994).